The effects of sodium-glucose cotransporters type 2 inhibitors on glycemic and extraglycemic laboratory parameters
ConclusionWhile SGLT2i seem to provide positive effects on the lipid profile, as well as their well-recognized effects on glycemic parameters, there may be value in further evaluating renal safety and the long-term alterations in lipid profile.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research
More News: Cardiology | Cardiovascular | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Empagliflozin | Endocrinology | Forxiga | Heart | Jardiance | Laboratory Medicine | Potassium | SGLT2 Inhibitors | Sodium | Study